Sky Oak Wealth, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Sky Oak Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 21, 2021	SELL	$169.75 - $207.73 $285,349 - $349,194	-1,681 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$128.63 - $176.89 $3,473 - $4,776	-27 Reduced 1.58%	1,681 $285,000
Q1 2021 Apr 29, 2021	SELL	$126.83 - $175.69 $232,986 - $322,742	-1,837 Reduced 51.82%	1,708 $245,000
Q4 2020 Feb 02, 2021	BUY	$122.97 - $147.0 $435,928 - $521,115	3,545 New	3,545 $461,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Sky Oak Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Sky Oak Wealth, LLC with notifications on news.